COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 1247: Articles 12461-12470  | Next

Identification of HLA-A*24:02-restricted CTL candidate epitopes derived from the non-structural polyprotein 1a of SARS-CoV-2 and analysis of their conservation using the mutation database of SARS-CoV-2 variants
Takagi, A., Matsui, M.
10.1101/2021.09.21.461322 — Posted: 2021-09-22
Design of Peptide Vaccine for COVID19: CD8+ and CD4+ T cell epitopes from SARS-CoV-2 open-reading-frame protein variants
Parn, S., Jabbour, G., Nguyenkhoa, V., Dakshanamurthy, S.
10.1101/2021.09.21.461301 — Posted: 2021-09-22
Comparative single-dose mRNA and ChAdOx1 vaccine effectiveness against SARS-CoV-2, including early variants of concern: a test-negative design, British Columbia, Canada
Skowronski, D. M., Setayeshgar, S., Zou, M., Prystajecky, N., Tyson, J. R., Sbihi, H., Fjell, C. D., Galanis, E., Naus, M., Patrick, D. M., El Adam, S., Ahmed, M., Kim, S., Henry, B., Hoang, L., Sadarangani, M., Jassem, A. N., Krajden, M.
10.1101/2021.09.20.21263875 — Posted: 2021-09-22 Discussion: Onsite
Impact of prior SARS-CoV-2 infection on post-vaccination SARS-CoV-2 spike IgG antibodies in a longitudinal cohort of healthcare workers
Zhong, D., Xiao, S., Debes, A. K., Egbert, E. R., Caturegli, P., Colantuoni, E., Milstone, A. M.
10.1101/2021.09.16.21263576 — Posted: 2021-09-22
Social relationships and activities following elimination of SARS-CoV-2: a qualitative cross-sectional study
Long, N. J., Appleton, N. S., Davies, S. G., Deckert, A., Fehoko, E., Holroyd, E., Martin-Anatias, N., Sterling, R., Trnka, S., Tunufa'i, L.
10.1101/2021.09.20.21263837 — Posted: 2021-09-22
The removal of airborne SARS-CoV-2 and other microbial bioaerosols by air filtration on COVID-19 surge units
Conway Morris, A., Sharrocks, K., Bousfield, R., Kermack, L., Maes, M., Higginson, E., Forrest, S., Pereira-Dias, J., Cormie, C., Old, T., Brooks, S., Hamed, I., Koenig, A., Turner, A., White, P., Floto, R. A., Dougan, G., Gkrania-Klotsas, E., Gouliouris, T., Baker, S., Navapurkar, V.
10.1101/2021.09.16.21263684 — Posted: 2021-09-22 Discussion: Onsite
COVID-19 Vaccine Hesitancy in India: An Exploratory Analysis
Agarwal, S. K., Naha, M.
10.1101/2021.09.15.21263646 — Posted: 2021-09-22
Did the COVID-19 pandemic result in more family physicians stopping practice? Results from Ontario, Canada
Kiran, T., Green, M. E., Wu, F. C., Kopp, A., Latifovic, L., Frymire, E., Glazier, R. H.
10.1101/2021.09.21.21263891 — Posted: 2021-09-22
Modeling the systemic risks of COVID-19 on the wildland firefighting workforce
Belval, E. J., Bayham, J., Thompson, M. P., Dilliott, J., Buchwald, A. G.
10.1101/2021.09.15.21263647 — Posted: 2021-09-22
Efficacy of SARS-CoV-2 wastewater surveillance for detection of COVID-19 at a residential private college
Landstrom, M., Braun, E., Larson, E., Miller, M., Holm, G. H.
10.1101/2021.09.15.21263338 — Posted: 2021-09-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).